← FDA Drug Approvals (Drugs@FDA)
CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2020-09-11
Drug application
- FDA Application #
ANDA212367- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
- Generic name
- Betamethasone Dipropionate
- Active ingredients
- BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- Dosage form
- SUSPENSION
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- PADAGIS ISRAEL
- First approval
- 2020-09-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown